merck & co. - Search News

Merck vaccine trial delayed

Merck vaccine trial delayed as RFK Jr. link creates jury concern

A lawyer for the plaintiff in the case said Merck agreed to halting the trial because his team feared that extensive publicity around Kennedy’s Senate confirmation hearings may taint the jury.

Becker's Hospital Review · 1d

Merck vaccine delayed mid-trial

Merck & Co.'s first trial over the safety of its blockbuster cancer vaccine Gardasil was postponed mid-trial due to concerns that jurors might be influenced by media coverage surrounding the confirmation of Robert F. Kennedy Jr. as HHS Secretary, Bloomberg reported Feb. 18.

Hosted on MSN · 2d

Exclusive-Merck vaccine case linked to HHS Secretary Kennedy delayed, company says

Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human Services Secretary Robert F.

STAT · 2d

Pharmalittle: We’re reading about Trump tariffs on drugs, a delayed Merck vaccine court trial, and more

President Trump told reporters that tariffs on pharmaceuticals would start at "25% or higher," but did not say when they would start

Seeking Alpha on MSN · 2d

Merck Gardasil trial adjourned after RFK Jr. becomes HHS secretary - report

Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the trial.

12h

MRK Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Merck & Co., Inc. Securities Class Action

SAN DIEGO, CA / ACCESS Newswire / February 20, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...

18h

Merck & Co. Inc. stock outperforms competitors on strong trading day

This was the stock's third consecutive day of gains.

FiercePharma2d

Amid Merck supply squeeze, ImmunityBio and Serum Institute snag FDA blessing for BCG expanded access program

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

22h

MRK INVESTOR DEADLINE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, ...

Beyond The Numbers: 13 Analysts Discuss Merck & Co Stock

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $112.46, a high ...

Seeking Alpha1d

MRK Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

2don MSN

Merck KGaA to replace two executives with company veterans

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

GlobalData on MSN2d

New CEOs to join Merck KGaA’s executive board

E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing ...

Shareholders That Lost Money on Merck & Co., Inc. (MRK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESS Newswire / February 20, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results